Adastra has become one of Canada's leaders in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. It serves medical markets and engages in forward-looking therapeutic applications. With cannabis concentrate products sold through retailers at more than 1,600 locations across Canada, Adastra's Phyto Extractions and Endgame Extracts brands are now well established with a solid distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Adastra partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market, with the ultimate aim of addressing the needs of patients. For more information, visit: www.adastraholdings.ca.
Company profile
Ticker
XTXXF
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
IRS number
120909627
Latest filings (excl ownership)
6-K
Condensed Interim Consolidated Financial Statements
6 Dec 23
6-K
Condensed Interim Consolidated Financial Statements
18 Aug 23
6-K
Condensed Interim Consolidated Financial Statements
31 May 23
20-F
2022 FY
Annual report (foreign)
17 May 23
6-K
Consolidated Financial Statements
4 May 23
6-K
Adastra Holdings Reports FY2022 Results; Demonstrating A Second Year of Record Revenue
4 May 23
NT 20-F
Notice of late annual filing (foreign)
26 Apr 23
6-K
Current report (foreign)
13 Apr 23
6-K
Current report (foreign)
20 Mar 23
6-K
Current report (foreign)
3 Mar 23
Latest ownership filings
No filings
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |